ID: ALA5285752

Max Phase: Preclinical

Molecular Formula: C27H32F3N5O

Molecular Weight: 499.58

Associated Items:

Representations

Canonical SMILES:  CCCCN1CCN(Cc2ccc(C(=O)Nc3cc(-n4cnc(C)c4)cc(C(F)(F)F)c3)cc2)CC1

Standard InChI:  InChI=1S/C27H32F3N5O/c1-3-4-9-33-10-12-34(13-11-33)18-21-5-7-22(8-6-21)26(36)32-24-14-23(27(28,29)30)15-25(16-24)35-17-20(2)31-19-35/h5-8,14-17,19H,3-4,9-13,18H2,1-2H3,(H,32,36)

Standard InChI Key:  ZOHAMXUZGJBJNY-UHFFFAOYSA-N

Associated Targets(Human)

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase ABL 18331 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Crk-like protein 7 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 499.58Molecular Weight (Monoisotopic): 499.2559AlogP: 5.37#Rotatable Bonds: 8
Polar Surface Area: 53.40Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.41CX LogP: 4.95CX LogD: 3.89
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.45Np Likeness Score: -1.74

References

1. Wang X, Xu Z, Feng J, Pan G, He X, Lv M, Chen H, Jiang W, Ji J, Yang M..  (2023)  Synthesis and biological evaluation of novel aromatic amide derivatives as potential BCR-ABL inhibitors.,  81  [PMID:36681201] [10.1016/j.bmcl.2023.129144]

Source